United States Biotechnology & Medical Research

Endocyte Inc (ECYT)

Track

Ticker: ECYT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Planned sale 9 Oct 2018
Value US$4,334,698.14 | Price 492.21 | Shares 26,922 (+21.2%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-10-09 2018-10-09 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
26,922 +21.2%
492.21
US$4,334,698 		26,922 +21.2% 492.21 US$4,334,698
2018-10-09 2018-10-05 PlS Planned sale Low Philip S

Chief Science Officer

Executive Director
13,810 +25.5%
455.39
US$3,070,057 		13,810 +25.5% 455.39 US$3,070,057
2018-10-09 2018-10-05 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
47,560 +48.2%
39.60
US$2,116,211 		47,560 +48.2% 39.60 US$2,116,211
2018-10-09 2018-10-05 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,022 -11.1%
15.56
US$109,287 		7,022 -11.1% 15.56 US$109,287
2018-10-09 2018-10-05 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
9,028 -6.9%
15.56
US$140,437 		9,028 -6.9% 15.56 US$140,437
2018-10-09 2018-10-05 PlS Planned sale Andriole Michael T.

Chief Financial Officer

Officer
17,283 -11.5%
15.55
US$268,783 		17,283 -11.5% 15.55 US$268,783
2018-10-09 2018-10-05 PlS Planned sale Sherman Michael A.

President and CEO

Executive Director
28,146 -7.5%
15.55
US$437,752 		28,146 -7.5% 15.55 US$437,752
2018-10-09 2018-10-05 PlS Planned sale Chelius Erik C.

Vice President CMC

Officer
4,514 -8.3%
15.56
US$70,243 		4,514 -8.3% 15.56 US$70,243
2018-10-09 2018-10-05 PlS Planned sale Parker Katherine

VP of Human Resources

Officer
6,771 -8.8%
15.55
US$105,316 		6,771 -8.8% 15.55 US$105,316
2018-08-29 2018-08-29 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
4,696 -3.5%
20.00
US$93,920 		4,696 -3.5% 20.00 US$93,920
2018-08-29 2018-08-28 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
7,892 -11.1%
20.00
US$157,840 		7,892 -11.1% 20.00 US$157,840
2018-08-29 2018-08-28 PlS Planned sale Leamon Christopher P

Vice President of Research

Officer
12,670 -8.9%
20.00
US$253,403 		12,670 -8.9% 20.00 US$253,403
2018-08-22 2018-08-20 PlS Planned sale Taylor Beth

VP Finance & Chief Acctg Offcr

Officer
285 -0.4%
18.20
US$5,187 		285 -0.4% 18.20 US$5,187
2018-08-02 2018-08-01 PlS Planned sale Armour Alison A.

Chief Medical Officer

Officer
1,414 -1.3%
15.98
US$22,589 		1,414 -1.3% 15.98 US$22,589
2018-06-13 2018-06-12 PlS Planned sale Leamon Christopher P

Vice President of Research
13,089 -9.1%
15.06
US$197,058 		13,089 -9.1% 15.06 US$197,058
2018-03-12 2018-03-09 PlS Planned sale Leamon Christopher P

Vice President of Research
5,036 -3.4%
9.07
US$45,677 		5,036 -3.4% 9.07 US$45,677
2018-01-02 2017-12-28 S Sale Low Philip S

Chief Science Officer

Executive Director
50,511 -14.3%
4.41
US$222,824 		50,511 -14.3% 4.41 US$222,824
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
5,037 -3.8%
5.05
US$25,434 		5,037 -3.8% 5.05 US$25,434
2017-12-04 2017-12-01 S Sale Leamon Christopher P

Vice President of Research
18,194 -12.1%
5.03
US$91,549 		18,194 -12.1% 5.03 US$91,549
2017-11-14 2017-11-13 B Purchase Low Philip S

Chief Science Officer

Executive Director
5,600 +2.0%
4.84
US$27,104 		5,600 +2.0% 4.84 US$27,104
2017-01-04 2016-12-30 S Sale Leamon Christopher P

Vice President of Research

Officer
23,244 -25.8%
2.55
US$59,272 		23,244 -25.8% 2.55 US$59,272
2016-05-12 2016-05-10 B Purchase Low Philip S

Chief Science Officer

Executive Director
11,375 +5.5%
3.52
US$40,040 		11,375 +5.5% 3.52 US$40,040
2016-01-20 2016-01-19 B Purchase MIDDLETON FRED A Non-Executive Director
10,000 +5.2%
2.79
US$27,900 		10,000 +5.2% 2.79 US$27,900
2016-01-20 2016-01-15 B Purchase MIDDLETON FRED A Non-Executive Director
20,000 +11.7%
2.80
US$56,000 		20,000 +11.7% 2.80 US$56,000
2015-03-05 2015-03-03 S Sale Nguyen Binh

VP of Medical Affairs

Officer
29,883 -51.3%
5.79
US$172,987 		29,883 -51.3% 5.79 US$172,987
2014-08-13 2014-08-11 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
21,479 -77.5%
7.00
US$150,353 		21,479 -77.5% 7.00 US$150,353
2013-09-16 2013-09-12 S Sale Meek David D.

Chief Commercial Officer

Officer
10,000 -100.0%
15.50
US$155,000 		10,000 -100.0% 15.50 US$155,000
2013-09-04 2013-08-30 S Sale Ritter Allen R

VP of Manufacturing/CMC

Officer
6,000 -25.3%
14.36
US$86,160 		6,000 -25.3% 14.36 US$86,160
2013-08-08 2013-08-06 S Sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
7,000 -100.0%
17.29
US$121,030 		7,000 -100.0% 17.29 US$121,030
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
131 -0.2%
14.25
US$1,867 		131 -0.2% 14.25 US$1,867
2013-05-29 2013-05-28 S Sale HANHAM ANN Non-Executive Director
1,569 -0.2%
14.25
US$22,358 		1,569 -0.2% 14.25 US$22,358
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
630 -1.1%
14.07
US$8,864 		630 -1.1% 14.07 US$8,864
2013-05-29 2013-05-24 S Sale HANHAM ANN Non-Executive Director
7,570 -1.1%
14.07
US$106,510 		7,570 -1.1% 14.07 US$106,510
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
1,259 -2.2%
14.39
US$18,117 		1,259 -2.2% 14.39 US$18,117
2013-05-22 2013-05-22 S Sale HANHAM ANN Non-Executive Director
15,141 -2.2%
14.39
US$217,879 		15,141 -2.2% 14.39 US$217,879
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
845 -1.5%
14.31
US$12,092 		845 -1.5% 14.31 US$12,092
2013-05-22 2013-05-21 S Sale HANHAM ANN Non-Executive Director
10,155 -1.5%
14.31
US$145,318 		10,155 -1.5% 14.31 US$145,318
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
967 -1.7%
14.42
US$13,944 		967 -1.7% 14.42 US$13,944
2013-05-22 2013-05-20 S Sale HANHAM ANN Non-Executive Director
11,633 -1.7%
14.42
US$167,748 		11,633 -1.7% 14.42 US$167,748
2013-05-21 2013-05-17 S Sale Nguyen Binh

VP of Clinical Affairs

Officer
17,300 -100.0%
14.42
US$249,466 		17,300 -100.0% 14.42 US$249,466
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
1,121 -1.9%
14.37
US$16,109 		1,121 -1.9% 14.37 US$16,109
2013-05-20 2013-05-17 S Sale HANHAM ANN Non-Executive Director
13,479 -1.9%
14.37
US$193,693 		13,479 -1.9% 14.37 US$193,693
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
1,735 -2.9%
14.44
US$25,053 		1,735 -2.9% 14.44 US$25,053
2013-05-20 2013-05-16 S Sale HANHAM ANN Non-Executive Director
20,865 -2.9%
14.44
US$301,291 		20,865 -2.9% 14.44 US$301,291
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
1,536 -2.5%
14.43
US$22,164 		1,536 -2.5% 14.43 US$22,164
2013-05-16 2013-05-15 S Sale HANHAM ANN Non-Executive Director
18,464 -2.5%
14.43
US$266,436 		18,464 -2.5% 14.43 US$266,436
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
1,551 -2.4%
14.94
US$23,172 		1,551 -2.4% 14.94 US$23,172
2013-05-16 2013-05-14 S Sale HANHAM ANN Non-Executive Director
18,649 -2.4%
14.94
US$278,616 		18,649 -2.4% 14.94 US$278,616
2013-05-16 2013-05-14 S Sale Leamon Christopher P

Vice President of Research

Officer
5,000 -33.2%
14.70
US$73,500 		5,000 -33.2% 14.70 US$73,500
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,993 -100.0%
9.70
US$19,332 		1,993 -100.0% 9.70 US$19,332
2013-02-26 2013-02-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
109 -100.0%
9.70
US$1,057 		109 -100.0% 9.70 US$1,057
2013-02-20 2013-02-19 PlS Planned sale Ritter Allen R

VP of Manufacturing/CMC

Officer
500 -14.4%
10.03
US$5,015 		500 -14.4% 10.03 US$5,015
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,659 -100.0%
9.56
US$15,860 		1,659 -100.0% 9.56 US$15,860
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
443 -100.0%
9.56
US$4,235 		443 -100.0% 9.56 US$4,235
2013-01-29 2013-01-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.56
US$1,023 		107 -100.0% 9.56 US$1,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,102 -100.0%
9.05
US$19,023 		2,102 -100.0% 9.05 US$19,023
2012-12-28 2012-12-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
107 -100.0%
9.05
US$968 		107 -100.0% 9.05 US$968
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
1,926 -100.0%
8.72
US$16,795 		1,926 -100.0% 8.72 US$16,795
2012-11-27 2012-11-26 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
283 -100.0%
8.72
US$2,468 		283 -100.0% 8.72 US$2,468
2012-10-29 2012-10-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
9.71
US$21,449 		2,209 -100.0% 9.71 US$21,449
2012-10-01 2012-09-28 S Sale Low Philip S

Chief Science Officer

Executive Director
34,000 -8.1%
9.99
US$339,810 		34,000 -8.1% 9.99 US$339,810
2012-09-27 2012-09-25 PlS Planned sale Lovejoy Chandra D

VP of Regulatory Affairs

Officer
2,209 -100.0%
10.28
US$22,709 		2,209 -100.0% 10.28 US$22,709
2012-08-17 2012-08-16 S Sale Leamon Christopher P

Vice President of Research

Officer
10,000 -39.9%
9.65
US$96,535 		10,000 -39.9% 9.65 US$96,535
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
24,181 -27.4%
6.60
US$159,674 		24,181 -27.4% 6.60 US$159,674
2012-06-07 2012-06-06 S Sale HANHAM ANN Non-Executive Director
290,719 -27.4%
6.60
US$1,919,705 		290,719 -27.4% 6.60 US$1,919,705
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
783 -0.9%
6.60
US$5,170 		783 -0.9% 6.60 US$5,170
2012-06-07 2012-06-05 S Sale HANHAM ANN Non-Executive Director
9,417 -0.9%
6.60
US$62,180 		9,417 -0.9% 6.60 US$62,180
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
2,142 -2.3%
6.65
US$14,246 		2,142 -2.3% 6.65 US$14,246
2012-05-18 2012-05-16 S Sale HANHAM ANN Non-Executive Director
25,758 -2.3%
6.65
US$171,306 		25,758 -2.3% 6.65 US$171,306
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
3,071 -3.3%
6.68
US$20,510 		3,071 -3.3% 6.68 US$20,510
2012-05-16 2012-05-15 S Sale HANHAM ANN Non-Executive Director
36,929 -3.3%
6.68
US$246,638 		36,929 -3.3% 6.68 US$246,638
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
8,215 -8.0%
6.94
US$56,974 		8,215 -8.0% 6.94 US$56,974
2012-05-16 2012-05-14 S Sale HANHAM ANN Non-Executive Director
98,785 -8.0%
6.94
US$685,113 		98,785 -8.0% 6.94 US$685,113
2011-12-22 2011-12-21 B Purchase SANDERLING VENTURES MANAGEMENT V Large shareholder
2,200 +6.7%
3.16
US$6,952 		2,200 +6.7% 3.16 US$6,952
2011-12-22 2011-12-21 B Purchase Sanderling Venture Partners V, LP Large shareholder
217,800 +33.3%
3.16
US$688,248 		217,800 +33.3% 3.16 US$688,248
Explore more

More insider trading research around Endocyte Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America